Loading...
Fenretinide Prevents Lipid-induced Insulin Resistance by Blocking Ceramide Biosynthesis
Fenretinide is a synthetic retinoid that is being tested in clinical trials for the treatment of breast cancer and insulin resistance, but its mechanism of action has been elusive. Recent in vitro data indicate that fenretinide inhibits dihydroceramide desaturase, an enzyme involved in the biosynthe...
Na minha lista:
Main Authors: | , , , , , , , , |
---|---|
Format: | Artigo |
Sprog: | Inglês |
Udgivet: |
American Society for Biochemistry and Molecular Biology
2012
|
Fag: | |
Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3366851/ https://ncbi.nlm.nih.gov/pubmed/22474281 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1074/jbc.M112.359950 |
Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|